Help - Search - Members - Calendar
Full Version: Cirrhosis
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Cirrhosis
Pages: 1, 2, 3, 4, 5, 6, 7, 8
  1. Cirrhosis: Clotted blood as sign of alcohol intoxication: a retrospective study (0 replies)
  2. Cirrhosis: Prolactin stimulates the proliferation of normal female cholangiocytes by differential regulation of ca2+-dependent pkc isoforms (0 replies)
  3. Cirrhosis: Shrnas targeting hepatitis c: effects of sequence and structural features, and comparision with sirna (0 replies)
  4. Cirrhosis: Non-alcoholic fatty liver disease: more than 'just a bit of fatty liver' (0 replies)
  5. Cirrhosis: Non-alcoholic fatty liver disease: what is it, when does it occur, and why does it matter? (0 replies)
  6. Cirrhosis: Lipomembranous panniculitis: report of a case. (0 replies)
  7. Cirrhosis: Constrictive pericarditis at abdominal ct: a commonly overlooked diagnosis (0 replies)
  8. Cirrhosis: The relationship between iron overload and clinical characteristics in a spanish cohort of 100 c282y homozygous hemochromatosis patients (0 replies)
  9. Cirrhosis: Constrictive pericarditis at abdominal ct: a commonly overlooked diagnosis. (0 replies)
  10. Cirrhosis: Evaluation of the protective effects of quercetin in the hepatopulmonary syndrome. (0 replies)
  11. Cirrhosis: High-molecular intestinal alkaline phosphatase in chronic liver diseases (0 replies)
  12. Cirrhosis: Combination of baseline bilirubin, alp, and ast effective biochemical predictor of udca therapy response for primary biliary cirrhosis (0 replies)
  13. Cirrhosis: Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease (0 replies)
  14. Cirrhosis: Hepatitis c cure announced by vcu researcher (0 replies)
  15. Cirrhosis: Hepatitis c cure announced by vcu researcher (0 replies)
  16. Cirrhosis: Acid–base disturbances in critically ill patients with cirrhosis (0 replies)
  17. Cirrhosis: Hydroxyzine administered at bedtime can improve sleep behaviour among patients with cirrhosis and minimal hepatic encephalopathy (0 replies)
  18. Cirrhosis: Th2 and regulatory immune reactions are increased in immunoglobin g4-related sclerosing pancreatitis and cholangitis (0 replies)
  19. Cirrhosis: Angiotensin ii type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis (0 replies)
  20. Cirrhosis: [commentaries] cardiovascular determinants of survival in cirrhosis (0 replies)
  21. Cirrhosis: [liver disease] diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt (0 replies)
  22. Cirrhosis: [letters] visceral leishmaniasis causes fever and decompensation in patients with cirrhosis (0 replies)
  23. Cirrhosis: Natural history of unexplained chronic hepatitis after liver transplantation (0 replies)
  24. Cirrhosis: Effect of a late evening snack on outpatients with liver cirrhosis. (0 replies)
  25. Cirrhosis: Immunopathogenesis of hepatitis c virus infection and hepatic fibrosis: new insights into antifibrotic therapy in chronic hepatitis c. (0 replies)
  26. Cirrhosis: Intracellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and primary biliary cirrhosis: in situ detection of 8-hydroxydeoxyguanosine and glutathione-s-transferase-pi. (0 replies)
  27. Cirrhosis: Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis. (0 replies)
  28. Cirrhosis: Ddw: hepatitis c patients benefit with new livers from hcv-infected donors (0 replies)
  29. Cirrhosis: Cure for hepatitis c announced by vcu researcher (0 replies)
  30. Cirrhosis: Paper: kentucky hepatoma: epidemiologic variant or same problem in a different region? (0 replies)
  31. Cirrhosis: Hydroxyzine administered at bedtime can improve sleep behaviour among patients with cirrhosis and minimal hepatic encephalopathy. (0 replies)
  32. Cirrhosis: Liver stiffness measurement can identify clinically significant and severe portal hypertension in patients with hcv-related cirrhosis (0 replies)
  33. Cirrhosis: Voriconazole: unconsciousness (first report) in a patient with cirrhosis: case report (0 replies)
  34. Cirrhosis: Long-term lamivudine therapy with or without adefovir improves outcome of evs in hbeag-negative patients with cirrhosis (0 replies)
  35. Cirrhosis: Bacterial infection-related morbidity and mortality in cirrhosis (0 replies)
  36. Cirrhosis: Liver stiffness tied to portal hypertension in cirrhosis (0 replies)
  37. Cirrhosis: Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma (0 replies)
  38. Cirrhosis: Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. (0 replies)
  39. Cirrhosis: Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis (0 replies)
  40. Cirrhosis: 'blue collar' men have double the death rate from cirrhosis (0 replies)
  41. Cirrhosis: Voriconazole: unconsciousness (first report) in a patient with cirrhosis: case report. (0 replies)
  42. Cirrhosis: Lipoprotein profile in cirrhosis of liver. (0 replies)
  43. Cirrhosis: Interim analysis: peginterferon alfa-2b maintenance therapy may reduce incidence of hcv-related hcc, cirrhosis complications (0 replies)
  44. Cirrhosis: Double the death rate from cirrhosis for "blue collar" men - university of queensland (0 replies)
  45. Cirrhosis: Reversibility of hepatic fibrosis and cirrhosis--is it all hype? (0 replies)
  46. Cirrhosis: Characteristics of persons with chronic hepatitis b--san francisco, california, 2006. (0 replies)
  47. Cirrhosis: Progress in hepatitis b prevention through universal infant vaccination--china, 1997-2006. (0 replies)
  48. Cirrhosis: Heavy or binge drinking is one of the main contributors to the development of liver cirrhosis in men (0 replies)
  49. Cirrhosis: Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump mrp4 in patients with primary biliary cirrhosis (0 replies)
  50. Cirrhosis: Qt interval analysis in patients with chronic liver disease: a prospective study (0 replies)
  51. Cirrhosis: A survey of chinese herbal ingredients with liver protection activities (0 replies)
  52. Cirrhosis: Adult living donor liver transplantation: living donation of the right liver lobe (0 replies)
  53. Cirrhosis: Prognostic models in cirrhosis: an aid but not a replacement for clinical judgement (0 replies)
  54. Cirrhosis: The role of psychological factors in the fatigue of primary biliary cirrhosis (0 replies)
  55. Cirrhosis: Intraperitoneal bleeding due to rupture of the left gastric vein (lgv) in a patient with liver cirrhosis: a case report (0 replies)
  56. Cirrhosis: Hepatitis c associated with lymphomas (0 replies)
  57. Cirrhosis: Steady-state pharmacokinetics of roflumilast and roflumilast n-oxide in patients with mild and moderate liver cirrhosis (0 replies)
  58. Cirrhosis: Ct and mri accurate for pre-transplant evaluation of patients with cirrhosis (0 replies)
  59. Cirrhosis: Ct and mri accurate for pre-transplant evaluation of patients with cirrhosis (0 replies)
  60. Cirrhosis: Liver stiffness measurement may predict severe portal hypertension (0 replies)
  61. Cirrhosis: Liver stiffness indicates portal hypertension (0 replies)
  62. Cirrhosis: Liver stiffness indicates portal hypertension (0 replies)
  63. Cirrhosis: Liver stiffness indicates portal hypertension (0 replies)
  64. Cirrhosis: The liver in brucellosis. (0 replies)
  65. Cirrhosis: D-penicillamine vs placebo/no intervention in patients with primary biliary cirrhosis. (0 replies)
  66. Cirrhosis: Liver stiffness predicts portal hypertension in hcv cirrhosis (0 replies)
  67. Cirrhosis: Cytotoxic t-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. (0 replies)
  68. Cirrhosis: New test helps identify hepatitis c patients at high risk of developing cirrhosis (0 replies)
  69. Cirrhosis: New test helps identify hepatitis c patients at high risk of developing cirrhosis (0 replies)
  70. Cirrhosis: Volume 44, number 11: wound infection and septic shock due to aeromonas trota in a patient with liver cirrhosis (0 replies)
  71. Cirrhosis: Atrial natriuretic factor after transjugular intrahepatic portosystemic shunt in liver cirrhosis and ascites (0 replies)
  72. Cirrhosis: A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis c (0 replies)
  73. Cirrhosis: Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. cme (0 replies)
  74. Cirrhosis: Long-term treatment with v2 receptor antagonist satavaptan effective for managing hyponatremia in patients with cirrhosis (0 replies)
  75. Cirrhosis: Relationship between transferrin-iron saturation, alcohol consumption, and the incidence of cirrhosis and liver cancer. (0 replies)
  76. Cirrhosis: Effects of lamivudine on serum albumin levels correlate with pretreatment hbv-dna levels in cirrhotic patients (0 replies)
  77. Cirrhosis: Antibody to hepatitis b core antigen and risk for hepatitis c-related hepatocellular carcinoma: a prospective study. (0 replies)
  78. Cirrhosis: Chmp recommends approval of peginterferon-alfa 2b monotherapy or in combination with ribavirin for treatment of adult patients with chronic hepatitis c (0 replies)
  79. Cirrhosis: Hepatitis c patients who are at high risk of developing cirrhosis can now be reliably identified (0 replies)
  80. Cirrhosis: Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with child–pugh class a liver cirrhosis: a 7-year follow-up study (0 replies)
  81. Cirrhosis: Essential hypertension and chronic viral hepatitis. (0 replies)
  82. Cirrhosis: Mucormycosis in patients with complicated cirrhosis. authors' reply. (0 replies)
  83. Cirrhosis: Mucormycosis in patients with complicated cirrhosis. (0 replies)
  84. Cirrhosis: Ascites in the state of qatar: aetiology and diagnostic value of ascitic fluid analysis. (0 replies)
  85. Cirrhosis: Genetic test indicates hepatitis c risk (0 replies)
  86. Cirrhosis: Celera to publish results of cirrhosis research (0 replies)
  87. Cirrhosis: Celera to publish results of cirrhosis research (0 replies)
  88. Cirrhosis: Gene test predicts risk of cirrhosis in chronic hepatitis c (0 replies)
  89. Cirrhosis: 7-gene signature predicts cirrhosis risk in patients with chronic hepatitis c (0 replies)
  90. Cirrhosis: New test helps identify hepatitis c patients at high risk of developing cirrhosis (0 replies)
  91. Cirrhosis: The expression of transforming growth factor-[alpha] in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. (0 replies)
  92. Cirrhosis: Carotid intima-media thickness in patients with liver cirrhosis associated with diabetes mellitus. (0 replies)
  93. Cirrhosis: Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using bayesian approach as sensitivity analyses (0 replies)
  94. Cirrhosis: Progression to cirrhosis in hepatitis c patients: an age-dependent process (0 replies)
  95. Cirrhosis: Hepatic disease as the first manifestation of progressive myoclonus epilepsy of lafora (0 replies)
  96. Cirrhosis: Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy. (0 replies)
  97. Cirrhosis: Extensive study on obesity and related liver problem launched by geisinger (0 replies)
  98. Cirrhosis: [mechanisms of signal transduction] mammalian tumor suppressor int6 specifically targets hypoxia inducible factor 2{alpha} for degradation by hypoxia- and pvhl-independent regulation (0 replies)
  99. Cirrhosis: [hepatobiliary imaging] focal nodular hyperplasia-like nodules in alcoholic liver cirrhosis: radiologic-pathologic correlation (0 replies)
  100. Cirrhosis: Serum sodium and hydration status predict transplant-free survival independent of meld score in patients with cirrhosis (0 replies)
  101. Cirrhosis: Chronic viral hepatitis and hepatocellular carcinoma (0 replies)
  102. Cirrhosis: Oxidative-inflammatory damage in cirrhosis: effect of vitamin e and a fermented papaya preparation (0 replies)
  103. Cirrhosis: Risk of betel quid chewing on the development of liver cirrhosis: a community-based case-control study. (0 replies)
  104. Cirrhosis: Wide hilar hepatico-jejunostomy: the optimum method of reconstruction after choledochal cyst excision (0 replies)
  105. Cirrhosis: [hepatitis] heterozygous {beta}-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis c (0 replies)
  106. Cirrhosis: [liver fibrosis] adenovirus-mediated expression of bmp-7 suppresses the development of liver fibrosis in rats (0 replies)
  107. Cirrhosis: Results of baraclude (entecavir) resistance monitoring programme presented at conference (0 replies)
  108. Cirrhosis: Subversion of innate host antiviral strategies by the hepatitis c virus. (0 replies)
  109. Cirrhosis: Liver regeneration may be simpler than previously thought (0 replies)
  110. Cirrhosis: Causes of death in patients with unresectable hepatocellular carcinoma (0 replies)
  111. Cirrhosis: Chylous ascites secondary to pancreatitis: management
    of an uncommon entity using parenteral nutrition and octreotide     (0 replies)
  112. Cirrhosis: Beneficial effect of partial portal decompression using the inferior mesenteric vein for intractable gastroesophageal variceal bleeding in patients with liver cirrhosis (0 replies)
  113. Cirrhosis: Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis (0 replies)
  114. Cirrhosis: Quercetin prevents oxidative stress in cirrhotic rats (0 replies)
  115. Cirrhosis: [original research] hepatic changes in the failing fontan circulation (0 replies)
  116. Cirrhosis: Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. (0 replies)
  117. Cirrhosis: Analysis: total hepatitis c cure possible (0 replies)
  118. Cirrhosis: Liver regeneration may be simpler than previously thought (0 replies)
  119. Cirrhosis: Levels of hepatitis b virus (hbv) replication during the nonreplicative phase: hbv quantification by real-time pcr in korea (0 replies)
  120. Cirrhosis: Liver regeneration may be simpler (0 replies)
  121. Cirrhosis: Analysis: u.s culture hurting eu livers? (0 replies)
  122. Cirrhosis: Bone disease in primary biliary cirrhosis and renal tubular acidosis: authors? reply (0 replies)
  123. Cirrhosis: Liver regeneration may be simpler than previously thought (0 replies)
  124. Cirrhosis: Renal tissue mast cells in liver diseases (0 replies)
  125. Cirrhosis: Early and late outcome of cardiac surgery in patients with liver cirrhosis (0 replies)
  126. Cirrhosis: Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension (0 replies)
  127. Cirrhosis: Clinical characteristics of idiopathic portal hypertension. (0 replies)
  128. Cirrhosis: Treatment of hepatitis c virus infection. (0 replies)
  129. Cirrhosis: Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman. (0 replies)
  130. Cirrhosis: A rare association of primary biliary cirrhosis with antiphopholipid antibody syndrome (0 replies)
  131. Cirrhosis: Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells (0 replies)
  132. Cirrhosis: A simple prognostic scoring system for patients with unresectable hepatocellular carcinoma treated by chemo-embolization. (0 replies)
  133. Cirrhosis: Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study. (0 replies)
  134. Cirrhosis: Distinct roles of free leptin, bound leptin, and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis (0 replies)
  135. Cirrhosis: Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis b cirrhosis 14 years after primary liver transplantation (0 replies)
  136. Cirrhosis: Vitamin e supplementation reverses renal altered vascular reactivity in chronic bile duct-ligated rats (0 replies)
  137. Cirrhosis: Molecular basis for calcium signaling in hepatic stellate cells (0 replies)
  138. Cirrhosis: Researchers identify critical receptor in liver regeneration (0 replies)
  139. Cirrhosis: Ucsd researchers identify critical receptor in liver regeneration (0 replies)
  140. Cirrhosis: Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hmsh2 genes. (0 replies)
  141. Cirrhosis: Adult to adult living-related liver transplant: report on an initial experience in italy. (0 replies)
  142. Cirrhosis: Melioidotic septic arthritis: a case report and literature review. (0 replies)
  143. Cirrhosis: Perioperative risk of hip arthroplasty in patients with cirrhotic liver disease. (0 replies)
  144. Cirrhosis: Animal models for autoimmune hepatitis. (0 replies)
  145. Cirrhosis: Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. (0 replies)
  146. Cirrhosis: Regional ileitis, ulcerative colitis, and clubbed fingers (0 replies)
  147. Cirrhosis: Researchers identify critical receptor in liver regeneration (0 replies)
  148. Cirrhosis: Effects of hepatitis c-induced liver fibrosis on survival in kidney transplant candidates (0 replies)
  149. Cirrhosis: Oh liver, heal thyself (0 replies)
  150. Cirrhosis: High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2009 Invision Power Services, Inc.